Log in
Enquire now
‌

US Patent 7750128 Modified Fc molecules

Patent 7750128 was granted and assigned to Amgen on July, 2010 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors
Is a
Patent
Patent
Current Assignee
Amgen
Amgen
Date Filed
August 1, 2008
Date of Patent
July 6, 2010
Patent Application Number
12221417
Patent Citations Received
‌
US Patent 11965025 Method of treating solid cancers with bispecific interleukin-anti-TCRß molecules
0
‌
US Patent 11685770 Stabilized receptor polypeptides and uses thereof
0
Patent Inventor Names
Colin Gegg
0
Fei Xiong
0
Karen C. Sitney
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
7750128
Patent Primary Examiner
‌
Sheela J. Huff

Find more entities like US Patent 7750128 Modified Fc molecules

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.